LONG-TERM SAFETY AND EFFICACY OF 4-WEEKLY CERTOLIZUMAB PEGOL MONOTHERAPY AND COMBINATION THERAPY IN RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM AN OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Fleischmann, R. [1 ]
van Vollenhoven, R. [2 ]
Vencovsky, J. [3 ]
Alten, R. [4 ]
Davies, O. [5 ]
Stach, C. [6 ]
de Longueville, M. [5 ]
VanLunen, B. [7 ]
Choy, E. [8 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Metroplex Clin Res Ctr, Dallas, TX 75390 USA
[2] Karolinska Inst, Stockholm, Sweden
[3] Inst Rheumatol, Prague, Czech Republic
[4] Charite, Schlosspk Klin, D-13353 Berlin, Germany
[5] UCB Pharma, Brussels, Belgium
[6] UCB Pharma, Monheim, Germany
[7] UCB Pharma, Raleigh, NC USA
[8] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：435 / 435
页数：1
相关论文
共 50 条
  • [21] A long-term, open-label trial of the safety and efficacy of etanercept (25 mg twice weekly) in patients with rheumatoid arthritis (final 5-year data)
    Klareskog, L
    Wajdula, J
    Pedersen, R
    Yeh, P
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 254 - 254
  • [22] Long-Term Safety and Efficacy of Certolizumab Pegol Therapy in Patients With Moderate to Severe Crohn's Disease: 5-Year Results
    Ptak, Theadore
    Younes, Ziad
    Shafran, Ira
    Lee, Scott
    Miner, Philip B.
    Kayhan, Cem
    Kosutic, Gordana
    Coarse, Jason
    Hasan, Iram
    Spearman, Marshall
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S774 - S775
  • [23] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Stanley Cohen
    Jose L. Pablos
    Karel Pavelka
    Gerard Anton Müller
    Alan Matsumoto
    Alan Kivitz
    Hui Wang
    Eswar Krishnan
    Arthritis Research & Therapy, 21
  • [24] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Cohen, Stanley
    Pablos, Jose L.
    Pavelka, Karel
    Mueller, Gerard Anton
    Matsumoto, Alan
    Kivitz, Alan
    Wang, Hui
    Krishnan, Eswar
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [25] LONG-TERM BENEFITS OVER MORE THAN 4 YEARS OF CERTOLIZUMAB PEGOL COMBINATION THERAPY ON WORKPLACE AND HOUSEHOLD PRODUCTIVITY, AND PARTICIPATION IN SOCIAL ACTIVITIES IN RHEUMATOID ARTHRITIS: RESULTS FROM THE OPEN-LABEL EXTENSION STUDY OF RAPID1
    Kavanaugh, A.
    Smolen, J. S.
    Emery, P.
    Keystone, E.
    Strand, V
    Purcaru, O.
    van Vollenhoven, R.
    VALUE IN HEALTH, 2013, 16 (07) : A570 - A570
  • [26] LONG-TERM SAFETY AND EFFICACY OF OLOKIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS - RESULT OF AN OPEN-LABEL EXTENSION STUDY, CREDO4
    Feist, E.
    Nasonov, E.
    Luggen, M.
    Fatenejad, S.
    Grishin, S.
    Samsonov, M.
    Fleischmann, R. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 593 - 593
  • [27] Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis
    Klareskog, L.
    Gaubitz, M.
    Rodriguez-Valverde, V.
    Malaise, M.
    Dougados, M.
    Wajdula, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 238 - 247
  • [28] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY
    Kivitz, A.
    Wells, A. F.
    Vargas, J. Ignacio
    Baraf, H. S. B.
    Rischmueller, M.
    Klaff, J.
    Khan, N.
    Li, Y.
    Carter, K.
    Friedman, A.
    Durez, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 620 - 621
  • [29] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
    Alan Kivitz
    Alvin F. Wells
    Juan I. Vargas
    Herbert S. B. Baraf
    Maureen Rischmueller
    Justin Klaff
    Nasser Khan
    Yihan Li
    Kyle Carter
    Alan Friedman
    Patrick Durez
    Rheumatology and Therapy, 2023, 10 : 901 - 915
  • [30] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY
    Kivitz, Alan
    Wells, Alvin F.
    Vargas, Juan I.
    Baraf, Herbert S. B.
    Rischmueller, Maureen
    Klaff, Justin
    Khan, Nasser
    Li, Yihan
    Carter, Kyle
    Friedman, Alan
    Durez, Patrick
    RHEUMATOLOGY, 2023, 62
12345